Related Experiment Video
Updated: Jun 26, 2026

Data Collection on Marine Litter Ingestion in Sea Turtles and Thresholds for Good Environmental Status
Published on: May 18, 2019
Better Data, Better Outcomes: Unified Macroplastic Ingestion Reporting Methods to Inform Risk Assessment
Erin Murphy1,2, Britta R Baechler1, Robson G Santos3
1Ocean Conservancy, Washington, D.C. 20036, United States.
None:
Addressing the impacts of plastic pollution, particularly plastic ingestion, on wildlife and ecosystems has become a priority for decision-makers developing management strategies. As nations design national action plans, the need for science-based targets to guide management objectives is increasingly urgent. Despite decades of evidence showing plastic ingestion in more than 1,500 species, our understanding of how ingestion affects organisms, populations, and ecosystems remains limited. Ecological risk assessments, which estimate the likelihood that a stressor will cause adverse effects at various biological levels, offer a pathway for identifying environmental thresholds. However, for macroplastic ingestion─an exposure pathway that cannot be ethically or feasibly studied in the laboratory─harmonized, large-scale environmental datasets are essential. Existing frameworks for reporting plastic ingestion are well suited for characterizing exposure in marine species, yet researchers often do not document observed harm in ways that support risk assessments. Here, we present a framework for collecting and reporting data on plastic ingestion in wildlife that better captures effects relevant to macroplastic risk assessment. Our framework builds on established ingestion protocols and introduces new approaches for measuring and reporting acute wildlife mortality and injuries attributable to plastic ingestion. Implementing this framework will continue to support long-term monitoring efforts, while improving our understanding of lethal and sublethal ingestion thresholds.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

